GM salmon: Will supermarket wariness sabotage rollout of first genetically engineered animal?

gmo salmon

After 17 years in the regulatory pipeline, the FDA appears close to approving of the AquAdvantage GM salmon. AquAdvantage salmon is a product of the Massachusetts-based biotech firm AquaBounty Technologies. Designed to reach market size in about half the time of standard farmed salmon, the fish would be the first genetically engineered animal approved for human consumption. Producers say the salmon is safe to eat, environmentally friendly and can feed more of the population with less resources, compared to other farmed fish.

The question remains: will grocery stores sell it? Last week Kroger and Safeway joined Whole Foods, Trader Joe’s, and Target in announcing they will not sell the GM salmon even if it is approved.

Anti-biotech groups have let their opposition be known, including  Dana Perls, a policy campaigner at the environmental organization Friends of the Earth who told Fox, “Before we say we’ve come up with a way to feed the growing population, what are we putting at risk in exchange?”

Jon Entine, the executive director of the Genetic Literacy Project thinks the public will come around. “Public perception is not necessarily negative, but suspicious,” he told Fox. “This is a marathon, not a sprint. Ten years from now the educated public is going to look back with a great sense of embarrassment at how fiercely groups that call themselves ‘progressive’ whipped up emotional concerns about whether GMOs are safe or sustainable. This opposition is based on ideology trumping science, at least in the short term.”

AquaBounty CEO Ron Stotish agrees: “American free enterprise has always worked well and it will continue to work well,” he told Fox. “If you have a good product, you will be successful.”

But how much can a good product overcome?

Read the full original article: GMO salmon may soon hit food stores, but will anyone buy it?

Additional Resources: 

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTC—a great idea. Here’s why it’s unlikely to happen
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
Screenshot-2026-05-04-at-12.54.32-PM
How Utah became the country’s supplement capital  — and a haven for unregulated, ineffective and fake products
Screenshot-PM-24
Viewpoint: The herbicide glyphosate isn’t perfect. Banning it would be far worse.
images
The never-ending GMO debate: Pros and cons
Screenshot-2026-05-01-at-11.56.24-AM
‘Science moves forward when people are willing to think differently’: Memories of DNA maverick Craig Venter
Screenshot-2026-04-03-at-11.15.51-AM
Paraben panic: How a flawed study, media hype, and chemophobia convinced the public of the danger of one of the safest classes of preservatives
Screenshot-2026-04-30-at-2.19.37-PM
5 myths about summer dehydration that could damage your health — or even kill you
Screenshot 2026-05-06 at 2.56
Singularity crisis ahead? Can super babies save us from rogue AI geniuses?
79d03212-2508-45d0-b427-8e9743ff6432
Viewpoint: The Casey Means hustle—Wellness woo opportunism dressed up as medical wisdom
bigstock opioids on chalkboard with rol
GLP podcast: 'Safe injection sites': enabling drug addiction or saving lives?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.